CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Faslodex ? in Recurrent/Metastatic Endometrial Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00006903
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:21.674662+00:00
Published At: 2014-06-24T00:00:00+00:00
Record Updated At: 2019-03-20
Results Posted At: 2014-06-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Recurrent Uterine Corpus Carcinoma", "Stage III Uterine Corpus Cancer AJCC v7", "Stage IV Uterine Corpus Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-03-20"
protocolSection.identificationModule.nctId: "NCT00006903"
protocolSection.identificationModule.officialTitle: "Phase II Study of Faslodex ? in Recurrent/Metastatic Endometrial Carcinoma"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-06-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.